Mallia Therapeutics
Mallia Therapeutics is a biopharmaceutical company focused on developing novel treatments to treat patients suffering from hair loss.
Mallia Therapeutics operates in biopharma, medical based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2023.
The company sits in the biopharma, medical segment, where it competes on its core product or service.
The business is associated with European Union (EU), Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Seed.
The company reports a headcount in the c_00001_00010 range.
| Sector | Biopharma, Medical |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2023 |
| Employees | c_00001_00010 |
| Stage | seed |
Website: mallia-therapeutics.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account